NDC Package 0023-9637-08 Oxytrol For Women

Oxybutynin Patch Transdermal - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0023-9637-08
Package Description:
32 PATCH in 1 CARTON / 4 d in 1 PATCH
Product Code:
Proprietary Name:
Oxytrol For Women
Non-Proprietary Name:
Oxybutynin
Substance Name:
Oxybutynin
Usage Information:
Oxybutynin is used to treat an overactive bladder. By relaxing the muscles in the bladder, oxybutynin improves symptoms such as the inability to control urination (incontinence), feeling that one has to urinate (urgency), and having to go to the bathroom often (frequency). This medication belongs to the class of drugs known as antispasmodics. This medication is not recommended for use in children younger than 5 years of age. Consult your doctor for more information. Unless otherwise directed by your doctor, the over-the-counter product should only be used by adult women who have symptoms of overactive bladder for at least 2 months. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.
11-Digit NDC Billing Format:
00023963708
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 403799 - oxyBUTYnin 3.9 MG/Day Twice Weekly Transdermal System
  • RxCUI: 403799 - 84 HR oxybutynin 0.162 MG/HR Transdermal System
  • RxCUI: 403799 - oxybutynin 0.162 MG/HR 84 HR Transdermal Patch
  • RxCUI: 403799 - oxybutynin 3.9 MG/Day Twice Weekly Transdermal Patch
  • RxCUI: 403799 - oxybutynin 3.9 MG/Day Twice Weekly Transdermal System
  • Product Type:
    Human Otc Drug
    Labeler Name:
    Allergan, Inc.
    Dosage Form:
    Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.
    Administration Route(s):
  • Transdermal - Administration through the dermal layer of the skin to the systemic circulation by diffusion.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA202211
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    01-01-2016
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0023-9637-0416 PATCH in 1 CARTON / 4 d in 1 PATCH

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0023-9637-08?

    The NDC Packaged Code 0023-9637-08 is assigned to a package of 32 patch in 1 carton / 4 d in 1 patch of Oxytrol For Women, a human over the counter drug labeled by Allergan, Inc.. The product's dosage form is patch and is administered via transdermal form.

    Is NDC 0023-9637 included in the NDC Directory?

    Yes, Oxytrol For Women with product code 0023-9637 is active and included in the NDC Directory. The product was first marketed by Allergan, Inc. on January 01, 2016 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0023-9637-08?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0023-9637-08?

    The 11-digit format is 00023963708. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20023-9637-085-4-200023-9637-08